(Q36032166)

11 August 2017

1 reference

title

Statistical considerations for vaccine immunogenicity trials. Part 2: Noninferiority and other statistical approaches to vaccine evaluation (English)

1 reference

11 August 2017

0 references

1

Brian D Plikaytis

1 reference

11 August 2017

2

George M Carlone

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

11 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

11 August 2017

volume

23

1 reference

11 August 2017

issue

13

1 reference

11 August 2017

page(s)

1606-1614

1 reference

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

Analysis of studies to evaluate immune response to combination vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

Power of the two one-sided tests procedure in bioequivalence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

Use of statistical models for evaluating antibody response as a correlate of protection against varicella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

The statistical analysis of immunogenicity data in vaccine trials. A review of methodologies and issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

"Proving the null hypothesis" in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

Establishing equivalence by showing that a specified percentage of the effect of the active control over placebo is maintained

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

Equivalence Testing for Binomial Random Variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

A new statistical procedure for testing equivalence in two-group comparative bioavailability trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

General design issues in efficacy, equivalency and superiority trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

General issues in efficacy, equivalency, and superiority trials: clinical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

The effect of experimental design parameters on the determination of sample size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

Trials to assess equivalence: the importance of rigorous methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.047

10.1016/J.VACCINE.2004.06.047

7 January 2021

Identifiers

DOI

1 reference

11 August 2017

1 reference